Coverage dated October 11, 2021 to October 13, 2021
J&J Covid-19 Vaccine Recipients May Benefit More From Pfizer Or Moderna Boosters, Study Finds
Headline from Forbes
J&J recipients who were administered Moderna or Pfizer boosters showed significantly higher antibody counts compared to those who received a booster of the same vaccine.
Forbes's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
NEW YORK -- Many Americans who got Pfizer vaccinations are rolling up their sleeves for a booster shot. Meanwhile, millions who received the Moderna or
WASHINGTON — With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.Federal regulators...
With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.
WASHINGTON — With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine
The U.S. Food and Drug Administration (FDA) will meet this week to debate whether or not extra doses of the Moderna, Inc. and Johnson & Johnson Janssen vaccines should be distributed, to whom and when.
After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters. Then next week, a panel convened by the Centers for Disease Control and Prevention will offer more specifics on who should get them.
Johnson & Johnson Covid-19 vaccine recipients are better off getting a booster shot from Pfizer or Moderna, a highly anticipated U.S. study suggested Wednesday. The National Institutes of Health study on “mixing and matching” Covid vaccines included more than 450 adults who have received one of the …
Should people who get a COVID booster get a different vaccine from their original shot? The results of a highly anticipated study suggest, that in some cases the answer may be yes.
A panel of outside of experts for the Food and Drug Administration is meeting this week to determine whether extra doses of the Moderna and Johnson & Johnson vaccines should be authorized and, if so, who should get them and when – but there are two factors complicating the matter.
The experts’ recommendations, though not binding, are likely to influence what the Food and Drug Administration decides on whether to authorize the boosters.
J&J recipients who were administered Moderna or Pfizer boosters showed significantly higher antibody counts compared to those who received a booster of the same vaccine.
The long-awaited study finds that people who got the J&J vaccine would benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot.
An NIH study on whether or not it is safe to “mix and match” vaccines found that people who initially received J&J vaccines had better protection against COVID-19 when they got a Moderna or Pfizer vaccine as a booster.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
J&J Covid-19 Vaccine Recipients May Benefit More From Pfizer Or Moderna Boosters, Study Finds | Since Then
